Mechanisms of Autoantibody-Induced Pathology

Ralf J. Ludwig(Lundbeck (Germany)), Karen Vanhoorelbeke(Research Institute for Chromatography), Frank Leypoldt(Christian-Albrechts-Universität zu Kiel), Ziya Kaya(Heidelberg University), Katja Bieber(Lundbeck (Germany)), Sandra M. McLachlan(Cedars-Sinai Medical Center), Lars Komorowski(Euroimmun Medizinische Labordiagnostika (Germany)), Jie Luo(University of Pennsylvania), Otávio Cabral-Marques(Lundbeck (Germany)), Christoph M. Hammers(Lundbeck (Germany)), Jon Lindstrom(University of Pennsylvania), Peter Lamprecht(Lundbeck (Germany)), Andrea Fischer(Heidelberg University), Gabriela Riemekasten(Lundbeck (Germany)), Claudia Tersteeg(Research Institute for Chromatography), Peter Sondermann(Max Planck Institute of Neurobiology), Basil Rapoport(Cedars-Sinai Medical Center), Klaus‐Peter Wandinger(University Hospital Schleswig-Holstein), Christian Probst(Euroimmun Medizinische Labordiagnostika (Germany)), Asmaa El Beidaq(University of Lübeck), Enno Schmidt(Lundbeck (Germany)), A. S. Verkman(University of California, San Francisco), Rudolf A. Manz(University of Lübeck), Falk Nimmerjahn(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Frontiers in Immunology
May 31, 2017
Cited by 460Open Access
Full Text

Abstract

Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis or Graves' disease. Overall, more than 2.5% of the population is affected by autoantibody-driven autoimmune disease. Pathways leading to autoantibody-induced pathology greatly differ among different diseases, and autoantibodies directed against the same antigen, depending on the targeted epitope, can have diverse effects. To foster knowledge in autoantibody-induced pathology and to encourage development of urgently needed novel therapeutic strategies, we here categorized autoantibodies according to their effects. According to our algorithm, autoantibodies can be classified into the following categories: (1) mimic receptor stimulation, (2) blocking of neural transmission, (3) induction of altered signaling, triggering uncontrolled (4) microthrombosis, (5) cell lysis, (6) neutrophil activation, and (7) induction of inflammation. These mechanisms in relation to disease, as well as principles of autoantibody generation and detection, are reviewed herein.


Related Papers

No related papers found

Powered by citation graph analysis